Clinical Trial: Novel ROS-scavenging Nanoenzymes for the Treatment of Radiation Dermatitis in Patients With Head and Neck Cancer

U.S., July 15 -- ClinicalTrials.gov registry received information related to the study (NCT07064577) titled 'Novel ROS-scavenging Nanoenzymes for the Treatment of Radiation Dermatitis in Patients With Head and Neck Cancer' on July 11.

Brief Summary: There is no standard treatment for radiation dermatitis. In this study, we have designed novel ROS-scavenging nanoenzymes and aim to evaluate their effectiveness in preventing radiation dermatitis in patients with head and neck cancer.

Study Start Date: July 15

Study Type: INTERVENTIONAL

Condition: Radiation Dermatitis

Intervention: DRUG: ROS-scavenging Nanoenzymes

ROS-scavenging nanoenzymes are applied to the treatment area, once daily during radiotherapy.

BEHAVIORAL: Standard of care...